Contineum Therapeutics (CTNM) Current Leases (2023 - 2025)
Historic Current Leases for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $1.5 million.
- Contineum Therapeutics' Current Leases rose 14173.49% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 14173.49%. This contributed to the annual value of $1.5 million for FY2024, which is 21293.1% up from last year.
- According to the latest figures from Q3 2025, Contineum Therapeutics' Current Leases is $1.5 million, which was up 14173.49% from $1.5 million recorded in Q2 2025.
- In the past 5 years, Contineum Therapeutics' Current Leases ranged from a high of $1.5 million in Q3 2025 and a low of $464000.0 during Q4 2023
- Its 3-year average for Current Leases is $985375.0, with a median of $1.0 million in 2024.
- In the last 5 years, Contineum Therapeutics' Current Leases surged by 21293.1% in 2024 and then soared by 14173.49% in 2025.
- Over the past 3 years, Contineum Therapeutics' Current Leases (Quarter) stood at $464000.0 in 2023, then surged by 212.93% to $1.5 million in 2024, then grew by 1.72% to $1.5 million in 2025.
- Its Current Leases was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.5 million in Q1 2025.